Product portfolio
Thirty-nine brands, every composition in full.
Filter by therapeutic area or search for a molecule. Compositions are listed exactly as they appear on the pack.
Showing all 39 brands
Newly launching
The Empawant range — empagliflozin, three ways.
SGLT2 inhibition paired with the DPP-4 agents prescribers already trust, plus the plain-molecule strengths for step-up therapy.
Empawant‑S 25 / 100
Empagliflozin 25 mg + Sitagliptin 100 mg Tablets
Empawant‑L 10 / 5
Empagliflozin 10 mg + Linagliptin 5 mg Tablets
Empawant 10 / 25
Empagliflozin 10 mg / 25 mg Tablets
Distribution
Want the price list for your territory?
Tell us where you operate and which segments you already move, and we will send the matching range with trade terms.